A New Mutation Causing Severe Infantile-Onset Pompe Disease Responsive to Enzyme Replacement Therapy

por Moravej, Hossein, Amirhakimi, Anis, Showraki, Alireza, Amoozgar, Hamid, Hadipour, Zahra, Nikfar, Ghasem
Publicado 2018

Purinergic receptors are a key bottleneck in tumor metabolic reprogramming: The prime suspect in cancer therapeutic resistance

por Aria, Hamid, Rezaei, Marzieh, Nazem, Shima, Daraei, Abdolreza, Nikfar, Ghasem, Mansoori, Behnam, Bahmanyar, Maryam, Tavassoli, Alireza, Vakil, Mohammad Kazem, Mansoori, Yaser
Publicado 2022